
Ventana TROP2 (EPR20043) RxDx Device Receives FDA Breakthrough Device Designation for Dato-DXd Selection in NSCLC
The FDA has granted breakthrough device designation to the Ventana TROP2 (EPR20043) RxDx Assay—an artificial intelligence (AI)–driven computational pathology device—to aid in the identification of patients with previously treated advanced or metastatic …